Activation of Nrf2/HO-1 Pathway and Human Atherosclerotic Plaque Vulnerability: An In Vitro and In Vivo Study

Reactive oxygen species (ROS) induce nuclear factor erythroid 2–related factor 2 (Nrf2) activation as an adaptive defense mechanism, determining the synthesis of antioxidant molecules, including heme-oxygenase-1 (HO-1). HO-1 protects cells against oxidative injury, degrading free heme and inhibiting ROS production. HO-1 is highly expressed in macrophages during plaque growth. Macrophages are morpho-functionally heterogeneous, and the prevalence of a specific phenotype may influence the plaque fate. This heterogeneity has also been observed in monocyte-derived macrophages (MDMs), a model of macrophages infiltrating tissue. The study aims to assess oxidative stress status and Nrf2/HO-1 axis in MDM morphotypes obtained from healthy subjects and coronary artery disease (CAD) patients, in relation to coronary plaque features evaluated in vivo by optical coherence tomography (OCT). We found that MDMs of healthy subjects exhibited a lower oxidative stress status, lower Nrf2 and HO-1 levels as compared to CAD patients. High HO-1 levels in MDMs were associated with the presence of a higher macrophage content, a thinner fibrous cap, and a ruptured plaque with thrombus formation, detected by OCT analysis. These findings suggest the presence of a relationship between in vivo plaque characteristics and in vitro MDM profile, and may help to identify patients with rupture-prone coronary plaque.

[1]  G. Niccoli,et al.  Biological profile of monocyte-derived macrophages in coronary heart disease patients: implications for plaque morphology , 2019, Scientific Reports.

[2]  R. Tian,et al.  Nitric oxide protected against NADPH oxidase-derived superoxide generation in vascular endothelium: Critical role for heme oxygenase-1. , 2019, International journal of biological macromolecules.

[3]  J. Kupiec-Weglinski,et al.  Myeloid HO-1 modulates macrophage polarization and protects against ischemia-reperfusion injury. , 2018, JCI insight.

[4]  A. M. Leone,et al.  Not all plaque ruptures are born equal: an optical coherence tomography study , 2017, European heart journal cardiovascular Imaging.

[5]  H. H. Ozgur,et al.  Diverse effects of taurine on vascular response and inflammation in GSH depletion model in rabbits. , 2016, European review for medical and pharmacological sciences.

[6]  Eloisa Arbustini,et al.  Identification and quantification of macrophage presence in coronary atherosclerotic plaques by optical coherence tomography. , 2015, European heart journal cardiovascular Imaging.

[7]  E. Tremoli,et al.  Human monocyte-derived macrophages are heterogenous: Proteomic profile of different phenotypes. , 2015, Journal of proteomics.

[8]  B. Staels,et al.  Macrophage subsets in atherosclerosis , 2015, Nature Reviews Cardiology.

[9]  Y. Naito,et al.  Heme oxygenase-1 and anti-inflammatory M2 macrophages. , 2014, Archives of biochemistry and biophysics.

[10]  Elena Tremoli,et al.  Nitric Oxide Synthetic Pathway in Red Blood Cells Is Impaired in Coronary Artery Disease , 2013, PloS one.

[11]  E. Tremoli,et al.  Human monocyte‐derived macrophages spontaneously differentiated in vitro show distinct phenotypes , 2013, Journal of cellular physiology.

[12]  H. Kim,et al.  Regulation of Monocyte Adhesion and Migration by Nox4 , 2013, PloS one.

[13]  F. Veglia,et al.  Direct glutathione quantification in human blood by LC-MS/MS: comparison with HPLC with electrochemical detection. , 2012, Journal of pharmaceutical and biomedical analysis.

[14]  M. Serafini,et al.  Oxidative stress in atherosclerosis development: the central role of LDL and oxidative burst. , 2012, Endocrine, metabolic & immune disorders drug targets.

[15]  J. Neubauer,et al.  Heme oxygenase-1 and chronic hypoxia , 2012, Respiratory Physiology & Neurobiology.

[16]  B. Miller,et al.  Phytochemical Activation of Nrf2 Protects Human Coronary Artery Endothelial Cells against an Oxidative Challenge , 2012, Oxidative medicine and cellular longevity.

[17]  Min Zhang,et al.  Heme Oxygenase-1, Oxidation, Inflammation, and Atherosclerosis , 2012, Front. Pharmacol..

[18]  Akiko Maehara,et al.  Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. , 2012, Journal of the American College of Cardiology.

[19]  S. yet,et al.  A central role of heme oxygenase-1 in cardiovascular protection. , 2011, Antioxidants & redox signaling.

[20]  W. Durante.  Protective role of heme oxygenase-1 against inflammation in atherosclerosis. , 2011, Frontiers in bioscience.

[21]  Agnes Pasquet,et al.  Imaging the vulnerable plaque. , 2011, Journal of the American College of Cardiology.

[22]  R. de Cabo,et al.  Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2 , 2010, American journal of physiology. Heart and circulatory physiology.

[23]  S. Nicholls,et al.  Biomarkers of inflammation and oxidative stress in atherosclerosis. , 2010, Biomarkers in medicine.

[24]  K. Chayama,et al.  Endothelial function in subjects with isolated low HDL cholesterol: role of nitric oxide and circulating progenitor cells. , 2010, American journal of physiology. Endocrinology and metabolism.

[25]  R. Krams,et al.  Activation of Nrf2 in Endothelial Cells Protects Arteries From Exhibiting a Proinflammatory State , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[26]  P. Serruys,et al.  Heme Oxygenase 1 Determines Atherosclerotic Lesion Progression Into a Vulnerable Plaque , 2009, Circulation.

[27]  C. B. Pickett,et al.  The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress* , 2009, Journal of Biological Chemistry.

[28]  F. Veglia,et al.  Glutathione, vitamin E and oxidative stress in coronary artery disease: relevance of age and gender , 2009, European journal of clinical investigation.

[29]  Y. Kiyohara,et al.  Overexpression of heme oxygenase-1 in coronary atherosclerosis of Japanese autopsies with diabetes mellitus: Hisayama study. , 2009, Atherosclerosis.

[30]  Erling Falk,et al.  Plaque rupture in humans and mice. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[31]  M. Kurrer,et al.  Constitutive Endocytosis of CD163 Mediates Hemoglobin-Heme Uptake and Determines the Noninflammatory and Protective Transcriptional Response of Macrophages to Hemoglobin , 2006, Circulation research.

[32]  Christof Karmonik,et al.  Quantitation and Localization of Matrix Metalloproteinases and Their Inhibitors in Human Carotid Endarterectomy Tissues , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[33]  Xue-Rui Tan,et al.  Haem oxygenase-1 expression and coronary heart disease – Association between levels of haem oxygenase-1 expression and angiographic morphology as well as the quantity of coronary lesions , 2006, Acta cardiologica.

[34]  S. Numazawa,et al.  Analysis of the expression of heme oxygenase-1 gene in human alveolar epithelial cells exposed to cigarette smoke condensate. , 2006, The Journal of toxicological sciences.

[35]  D. Newby,et al.  Depressed glutathione synthesis precedes oxidative stress and atherogenesis in Apo-E(-/-) mice. , 2005, Biochemical and biophysical research communications.

[36]  T. Morita.  Heme Oxygenase and Atherosclerosis , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[37]  S. Remy,et al.  Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. , 2005, Blood.

[38]  Yu-guang Li,et al.  Study on changes of heme oxygenase‐1 expression in patients with coronary heart disease , 2005, Clinical cardiology.

[39]  Brett E. Bouma,et al.  In Vivo Characterization of Coronary Atherosclerotic Plaque by Use of Optical Coherence Tomography , 2005, Circulation.

[40]  T. Kodama,et al.  Bilirubin From Heme Oxygenase-1 Attenuates Vascular Endothelial Activation and Dysfunction , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[41]  Antonio Colombo,et al.  Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. , 2004, European heart journal.

[42]  M. Yokoyama.  Oxidant stress and atherosclerosis. , 2004, Current opinion in pharmacology.

[43]  K. Itoh,et al.  Downloaded from http://circres.ahajournals.org / by guest on February 23, 2013Role of Nrf2 in the Regulation of CD36 and Stress Protein Expression in Murine Macrophages Activation by Oxidatively Modified LDL and 4-Hydroxynonenal , 2004 .

[44]  N. Sibinga,et al.  Absence of heme oxygenase‐1 exacerbates atherosclerotic lesion formation and vascular remodeling , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  A. Whorton,et al.  Nitric oxide stimulates Nrf2 nuclear translocation in vascular endothelium. , 2003, Biochemical and biophysical research communications.

[46]  E. Halpern,et al.  Quantification of Macrophage Content in Atherosclerotic Plaques by Optical Coherence Tomography , 2003, Circulation.

[47]  H. Hashimoto,et al.  Heme Oxygenase-1 Gene Promoter Polymorphism Is Associated With Coronary Artery Disease in Japanese Patients With Coronary Risk Factors , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[48]  Rui Wang,et al.  Selective Regulation of Blood Pressure by Heme Oxygenase-1 in Hypertension , 2002, Hypertension.

[49]  J. Auwerx,et al.  Oxidized phospholipids inhibit cyclooxygenase-2 in human macrophages via nuclear factor-κB/IκB- and ERK2-dependent mechanisms , 2002 .

[50]  O. Wagner,et al.  Heme Oxygenase-1 Genotype is a Vascular Anti-inflammatory Factor following Balloon Angioplasty , 2002, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[51]  W. Pan,et al.  Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients , 2002, Human Genetics.

[52]  K. Seung,et al.  Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. , 2002, Journal of the American College of Cardiology.

[53]  Y. Oda,et al.  Heme oxygenase-1 deficiency: the first autopsy case. , 2002, Human pathology.

[54]  J. Auwerx,et al.  Oxidized phospholipids inhibit cyclooxygenase-2 in human macrophages via nuclear factor-kappaB/IkappaB- and ERK2-dependent mechanisms. , 2002, Cardiovascular research.

[55]  D. Sugawara,et al.  Heme Oxygenase-1 Inhibits Atherogenesis in Watanabe Heritable Hyperlipidemic Rabbits , 2001, Circulation.

[56]  A. Lusis,et al.  Heme Oxygenase-1 Inhibits Atherosclerotic Lesion Formation in LDL-Receptor Knockout Mice , 2001, Circulation research.

[57]  E. Tremoli,et al.  Oxidized low density lipoprotein suppresses expression of inducible cyclooxygenase in human macrophages. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[58]  Tzong-Shyuan Lee,et al.  Expression of heme oxygenase-1 in atherosclerotic lesions. , 1998, The American journal of pathology.

[59]  A. Lusis,et al.  Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. , 1997, The Journal of clinical investigation.

[60]  M. Maines,et al.  Glutathione Depletion Induces Heme Oxygenase‐1 (HSP32) mRNA and Protein in Rat Brain , 1993, Journal of neurochemistry.

[61]  J. Eaton,et al.  Ferritin: a cytoprotective antioxidant strategem of endothelium. , 1992, The Journal of biological chemistry.